These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36976308)

  • 1. Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study.
    Garavelas A; Mallis P; Michalopoulos E; Nikitos E
    Medicines (Basel); 2023 Feb; 10(3):. PubMed ID: 36976308
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.
    Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N
    Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women.
    Sfakianoudis K; Simopoulou M; Grigoriadis S; Pantou A; Tsioulou P; Maziotis E; Rapani A; Giannelou P; Nitsos N; Kokkali G; Koutsilieris M; Pantos K
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32532000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraovarian Platelet-Rich Plasma Injections: Safety and Thoughts on Efficacy Based on a Single Centre Experience With 469 Women.
    Fraidakis M; Giannakakis G; Anifantaki A; Skouradaki M; Tsakoumi P; Bitzopoulou P; Kourpa S; Zervakis A; Kakouri P
    Cureus; 2023 May; 15(5):e38674. PubMed ID: 37288228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study.
    Barad DH; Albertini DF; Molinari E; Gleicher N
    Hum Reprod Open; 2022; 2022(3):hoac027. PubMed ID: 35795849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraovarian Injection of Autologous Platelet-Rich Plasma Improves Therapeutic Approaches in The Patients with Poor Ovarian Response: A Before-After Study.
    Navali N; Sadeghi L; Farzadi L; Ghasemzadeh A; Hamdi K; Hakimi P; Niknafs B
    Int J Fertil Steril; 2022 Apr; 16(2):90-94. PubMed ID: 35639652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Rejuvenation Through Platelet-Rich Autologous Plasma (PRP)-a Chance to Have a Baby Without Donor Eggs, Improving the Life Quality of Women Suffering from Early Menopause Without Synthetic Hormonal Treatment.
    Petryk N; Petryk M
    Reprod Sci; 2020 Nov; 27(11):1975-1982. PubMed ID: 32700285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency.
    Cakiroglu Y; Saltik A; Yuceturk A; Karaosmanoglu O; Kopuk SY; Scott RT; Tiras B; Seli E
    Aging (Albany NY); 2020 Jun; 12(11):10211-10222. PubMed ID: 32507764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.
    Xu J; Bishop CV; Lawson MS; Park BS; Xu F
    Hum Reprod; 2016 Jul; 31(7):1522-30. PubMed ID: 27165618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma.
    Sills ES; Rickers NS; Li X; Palermo GD
    Gynecol Endocrinol; 2018 Sep; 34(9):756-760. PubMed ID: 29486615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF-mobilized peripheral blood mononuclear cells combined with platelet-rich plasma accelerate restoration of ovarian function in cyclophosphamide-induced POI rats†.
    Huang Q; Liu B; Jiang R; Liao S; Wei Z; Bi Y; Liu X; Deng R; Jin Y; Tan Y; Yang Y; Qin A
    Biol Reprod; 2019 Jul; 101(1):91-101. PubMed ID: 31034039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study.
    Hosseinisadat R; Farsi Nejad A; Mohammadi F
    Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():60-63. PubMed ID: 36403398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency.
    Panda SR; Sachan S; Hota S
    Cureus; 2020 Dec; 12(12):e12037. PubMed ID: 33457137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Use of Autologous Bone Marrow-derived Stem Cells and Platelet-rich Plasma for Ovarian Rejuvenation in Poor Responders.
    Tandulwadkar S; Karthick MS
    J Hum Reprod Sci; 2020; 13(3):184-190. PubMed ID: 33311903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resumed ovarian function and pregnancy in early menopausal women by whole dimension subcortical ovarian administration of platelet-rich plasma and gonadotropins.
    Hsu CC; Hsu I; Hsu L; Chiu YJ; Dorjee S
    Menopause; 2021 Mar; 28(6):660-666. PubMed ID: 33784262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment.
    Pantos K; Simopoulou M; Pantou A; Rapani A; Tsioulou P; Nitsos N; Syrkos S; Pappas A; Koutsilieris M; Sfakianoudis K
    Cell Transplant; 2019; 28(9-10):1333-1340. PubMed ID: 31271054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evaluation of Ovarian Function Recovery Following Treatment of Primary Ovarian Insufficiency: A Systematic Review.
    Kuang X; Tang Y; Xu H; Ji M; Lai D
    Front Endocrinol (Lausanne); 2022; 13():855992. PubMed ID: 35573993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A narrative review of platelet-rich plasma (PRP) in reproductive medicine.
    Sharara FI; Lelea LL; Rahman S; Klebanoff JS; Moawad GN
    J Assist Reprod Genet; 2021 May; 38(5):1003-1012. PubMed ID: 33723748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria.
    Farimani M; Nazari A; Mohammadi S; Anvari Aliabad R
    Reprod Biol Endocrinol; 2021 Sep; 19(1):137. PubMed ID: 34496887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study.
    Melo P; Navarro C; Jones C; Coward K; Coleman L
    J Assist Reprod Genet; 2020 Apr; 37(4):855-863. PubMed ID: 32030554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.